Event Details

Who should attend?

biotech, pharma

Details

TWO EVENTS-ONE WEEK!
ETS-2012 is a yearly event with emphasis on promising approaches and challenges in the accurate prediction of adverse drug effects during drug development. This year’s theme will be earlier evaluation of neurotoxicity, hepatotoxicity, cardiotoxicity, stem cell toxicity, and novel HTS, 3-D culture, and multiple cell co-culture systems, with academic and industrial experts presenting data. Topics covered will be under the categories of Scientific Concepts of Transporters and Drug Interactions; Clinical Evidence of Transporter-related Drug Toxicity; and Experimental Approaches for Transporter-related Drug toxicity.

Session I: Neurotoxicity
Session II: Hepatotoxicity and Cardiotoxicity
Session III: Stem Cell and Bone Marrow Toxicity
Session IV: High-throughput, 3-D and Co-culture Technologies

DDI-2012 is a yearly event providing a comprehensive update on the status of the science of drug-drug interactions and its relevance to drug development. Presentations will be given by experts from industry and academia. Topics covered will include literature and NDA reviews, mechanism and in vitro-in vivo extrapolation of DDI via enzyme and transporter inhibition and induction. The conference will also include a review on the current status of DDI potential of Biotherapeutics.

Pre-conference Workshop: Novel Approaches and Concepts in Drug-drug Interactions
Session I: Evaluation of Complex Drug-drug Interactions
Session II: Novel Approaches to Improve Prediction of In Vivo Drug-drug Interactions

DDI-2012-Main Conference
Session I: Literature and NDA Review
Session II: Mechanism-based Enzyme Inhibition
Session III: Enzyme Inhibition
Session IV: Transporters
Session V: Biotherapeutics

Prices

Early Registration discount ends May 11, 2012

Contact

Nola Mahaney
nola@ifscomm.org